Development of a Phase Transfer Catalyzed Asymmetric Synthesis for an Estrogen Receptor Beta Selective Agonist
Citations Over TimeTop 24% of 2007 papers
Abstract
A practical asymmetric synthesis of the estrogen receptor beta selective agonist (7β-9aβ)-1,4-dichloro-2-hydroxygibba-1(10a),2,4,4b-tetraen-6-one (1), proceeding by way of six isolated intermediates and without recourse to chromatography, is described. Highlights of the process route developed are two chemoselective chlorinations, a lithiated hydrazone alkylation and an asymmetric Michael addition of indanone 11 to methyl vinyl ketone (using 15 mol % of cinchonine-derived catalyst 20g) to set the all-carbon quaternary asymmetric stereocenter. The challenges addressed in scaling the latter heterogeneous biphasic phase transfer reaction to 44 mol (14 kg) scale are discussed in detail. Overall, the chemistry developed has been used to prepare >6 kg of drug candidate 1 in 18% overall yield and with >99% ee.
Related Papers
- → Enantioselective Synthesis of Chiral α-Thio-Quaternary Stereogenic Centers via Phase-Transfer-Catalyzed α-Alkylation of α-Acylthiomalonates(2017)7 cited
- → Highly Enantioselective Construction of Quaternary Stereocenters on β‐Keto Esters by Phase‐Transfer Catalytic Asymmetric Alkylation and Michael Reaction(2003)54 cited
- → Construction of Chiral α-Amino Quaternary Stereogenic Centers via Phase-Transfer Catalyzed Enantioselective α-Alkylation of α-Amidomalonates(2015)18 cited
- → Highly Enantioselective Construction of Quaternary Stereocenters on β‐Keto Esters by Phase‐Transfer Catalytic Asymmetric Alkylation and Michael Reaction(2003)1 cited
- → ChemInform Abstract: Phase‐Transfer Catalyzed Enantioselective α‐Alkylation of α‐Acyloxymalonates: Construction of Chiral α‐Hydroxy Quaternary Stereogenic Centers.(2016)